Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs Trava Health

PlexusDx
Graded #158

Lower grade

vs+0.8999999999999915
Trava Health
Graded #144

Higher grade

The verdict

Trava Health takes it — 68.6/100 to 67.7/100, but only just.

Trava Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages… PlexusDx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrava Health +6
74
80
Dose & formulationEven
64
64
Clinical oversightPlexusDx +5
74
69
Labs & monitoringEven
52
52
FulfillmentTrava Health +4
78
82
Contract termsEven
55
55
PlexusDx · left barTrava Health · right bar

The numbers

MetricPlexusDxTrava Health
WeighScore67.7/10068.6/100
GradeCC
Scorecard rank#158#144
Semaglutide$149/mo (starting dose, compounded)$119/mo (starting dose, compounded)
Tirzepatide$249/mo (starting dose, compounded)$198/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
Trava Health

Graded #144 · C

Strengths

  • Six named compounding pharmacy partners disclosed in 3rd-party reviews
  • Independent batch testing by Eagle Analytical (FDA-registered lab)
  • Free overnight shipping included
  • No membership fee — pay only for medication
  • HSA/FSA eligible

Where it loses points

  • No LegitScript accreditation badge surfaced
  • BBB F rating with 2 unanswered complaints (BBB file opened 2025-07-07)
  • Clinician roster page returns 404 — no public team listing
  • Founder/CEO not publicly named on site
  • Higher dose pricing gated behind questionnaire (not transparent on public page)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard